Refining Classification of Cholangiocarcinoma Subtypes via Proteogenomic Integration Reveals New Therapeutic Prospects-Reference-Cited by-同舟云学术

Refining Classification of Cholangiocarcinoma Subtypes via Proteogenomic Integration Reveals New Therapeutic Prospects

Published:2023-06 Issue:7 Volume:164 Page:1293-1309
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Cho Soo Young,Hwang Heeyoun,Kim Yun-Hee,Yoo Byong Chul,Han Nayoung,Kong Sun-Young,Baek Min-Jeong,Kim Kyung-Hee,Lee Mi Rim,Park Jae Gwang,Han Sung-Sik,Lee Woo Jin,Park Charny,Park Jong Bae,Kim Jin Young,Park Sang-Jae,Woo Sang Myung^ORCID

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference46 articles.

1. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors;Nakeeb;Ann Surg,1996

2. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer;Valle;N Engl J Med,2010

3. Precision medicine for patients with advanced biliary tract cancers: an effective strategy within the prospective MOSCATO-01 trial;Verlingue;Eur J Cancer,2017

4. TAS-120 overcomes resistance to ATP-Competitive FGFR inhibitors in patients with FGFR2 fusion-positive intrahepatic cholangiocarcinoma;Goyal;Cancer Discov,2019

5. New horizons for precision medicine in biliary tract cancers;Valle;Cancer Discov,2017

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveil Intrahepatic Cholangiocarcinoma Heterogeneity through the Lens of Omics and Multi-Omics Approaches;Cancers;2024-08-20

2. Proteomics Profiling of Bilirubin Nanoparticle Treatment against Myocardial Ischemia-Reperfusion Injury;Journal of Proteome Research;2024-08-09

3. PTEN status determines therapeutic vulnerability to celastrol in cholangiocarcinoma;Phytomedicine;2024-08

4. Patient-derived organoid models to decode liver pathophysiology;Trends in Endocrinology & Metabolism;2024-08

5. Efficacy and safety of maintenance therapy with anlotinib for advanced cholangiocarcinoma after first-line chemotherapy and the variations in efficacy based on different neutrophil-to-lymphocyte ratio (NLR);World Journal of Surgical Oncology;2024-07-29